Combined metoprolol and ascorbic acid treatment prevents intrinsic damage to the heart during diabetic cardiomyopathy

Canadian Journal of Physiology and Pharmacology

Volumn 92, Issue 10, 2014, Pages 827-837

  Saran, Varun ^a   Sharma, Vijay ^b   Wambolt, Richard ^a   Yuen, Violet G ^b   Allard, Michael ^a   McNeill, John Hugh ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antioxidant; Cardiac function; Diabetes; Metabolism; Oxidative stress; blocker

Indexed keywords

ASCORBIC ACID; METOPROLOL; ANTIOXIDANT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIABETIC CARDIOMYOPATHY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART INJURY; HEART OUTPUT; HEART PERFUSION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SYSTOLIC DYSFUNCTION; ANIMAL; DIABETIC CARDIOMYOPATHIES; DRUG COMBINATION; DRUG EFFECTS; HEART; HEART MUSCLE; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; DIABETIC CARDIOMYOPATHIES; DRUG THERAPY, COMBINATION; HEART; MALE; METOPROLOL; MYOCARDIUM; OXIDATIVE STRESS; RATS, WISTAR;

EID: 84907551488     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0078     Document Type: Article

References (40)

1. Allard, M.F., Wambolt, R.B., Longnus, S.L., Grist, M., Lydell, C.P., Parsons, H.L., et al. 2000. Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin. Am. J. Physiol. Endocrinol. Metab. 279: E487- E493. PMID:10950814.
2. Ally, A., and Park, G. 1992. Rapid determination of creatine, phosphocreatine, purine bases and nucleotides (ATP, ADP, AMP, GTP, GDP) in heart biopsies by gradient ion-pair reversed-phase liquid chromatography. J. Chromatogr. 575: 19-27. doi:10.1016/0378-4347(92)80499-G. PMID:1517298.
3. American Diabetes Association. 2003. Economic costs of diabetes in the U.S. in 2002. Diabetes Care, 26: 917-932. doi:10.2337/diacare.26.3.917. PMID: 12610059.
4. Aydemir-Koksoy, A., Bilginoglu, A., Sariahmetoglu, M., Schulz, R., and Turan, B. 2010. Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress. J. Nutr. Biochem. 21: 827-833. doi:10.1016/j.jnutbio.2009.06.006. PMID:19954952.
5. Barr, R., and Lopaschuk, G.D. 1997. Measurements of energy metabolism in the isolated heart. Edited by J.H. McNeill. CRC, Boca Raton, Fla.
6. Bell, D.S. 1995. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care, 18: 708-714. doi:10.2337/diacare.18.5. 708. PMID:8586013.
7. Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P.M., Chen, J., et al. 2001. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes, 50: 2792-2808. doi:10.2337/ diabetes.50.12.2792. PMID:11723063.
8. Brunvand, H., Liu, G., Ma, X., Yue, T., Ruffolo, R.R., and Feuerstein, G.Z. 1998. SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits. Eur. J. Pharmacol. 356: 193-198. doi: 10.1016/S0014-2999(98)00494-4. PMID:9774249.
9. Buettner, R., Newgard, C.B., Rhodes, C.J., and O’Doherty, R.M. 2000. Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia. Am. J. Physiol. Endocrinol. Metab. 278: E563-E569. PMID:10710512.
10. Bugger, H., Boudina, S., Hu, X.X., Tuinei, J., Zaha, V.G., Theobald, H.A., et al. 2008. Type 1 diabetic Akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes, 57: 2924-2932 doi:10.2337/db08-0079. PMID: 18678617.
11. Canadian Diabetes Association. 2011. The prevalence and costs of diabetes.
12. Cunningham, J.J., Mearkle, P.L., and Brown, R.G. 1994. Vitamin C: an aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes mellitus. J. Am. Coll. Nutr. 13: 344-350. doi:10.1080/07315724.1994. 10718420. PMID:7963139.
13. Dai, S., and McNeill, J.H. 1995. Ascorbic acid supplementation prevents hyperlipidemia and improves myocardial performance in streptozotocin-diabetic rats. Diabetes Res. Clin. Pract. 27: 11-18. doi:10.1016/0168-8227(94)01013-P. PMID:7781489.
14. Di Bonito, P., Cuomo, S., Moio, N., Sibilio, G., Sabatini, D., Quattrin, S., and Capaldo, B. 1996. Diastolic dysfunction in patients with non-insulin-dependent diabetesmellitusofshortduration.Diabet.Med.13:321-324.doi:10.1002/(SICI)1096- 9136(199604)13:4<321::AID-DIA3>3.3.CO;2-Z. PMID:9162606.
15. Falcão-Pires, I., and Leite-Moreira, A.F. 2011. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail. Rev. 17(3): 325-344. doi:10.1007/s10741-011-9257-z. PMID: 21626163.
16. Fang, Z.Y., Yuda, S., Anderson, V., Short, L., Case, C., and Marwick, T.H. 2003. Echocardiographic detection of early diabetic myocardial disease. J. Am. Coll. Cardiol. 41: 611-617. doi:10.1016/S0735-1097(02)02869-3. PMID:12598073.
17. Fowler, M.J. 2008. Microvascular and macrovascular complications of diabetes. Clin. Diabetes, 26: 77-82. doi:10.2337/diaclin.26.2.77.
18. Guyton, A.C., Lindsey, A.W., Abernathy, B., and Langston, J.B. 1958. Mechanism of the increased venous return and cardiac output caused by epinephrine. Am. J. Physiol. 192: 126-130. PMID:13498163.
19. Heart Failure Society of America. 2000. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction: pharmacological approaches. Heart Failure Society of America. Pharmacotherapy, 20: 495-522. PMID:10809338.
20. Henning, S.L., Wambolt, R.B., Schonekess, B.O., Lopaschuk, G.D., and Allard, M.F. 1996. Contribution of glycogen to aerobic myocardial glucose utilization. Circulation, 93: 1549-1555. doi:10.1161/01.CIR.93.8.1549. PMID: 8608624.
21. Hoit, B.D., Castro, C., Bultron, G., Knight, S., and Matlib, M.A. 1999. Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocininduced diabetic rats. J. Card. Fail. 5: 324-333. doi:10.1016/S1071-9164(99) 91337-4. PMID:10634674.
22. How, O.J., Aasum, E., Severson, D.L., Chan, W.Y., Essop, M.F., and Larsen, T.S. 2006. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes, 55: 466-473. doi:10.2337/diabetes.55.02.06.db05- 1164. PMID:16443782.
23. Hunt, S.A., Baker, D.W., Chin, M.H., Cinquegrani, M.P., Feldmanmd, A.M., Francis, G.S., et al. 2001. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation, 104: 2996-3007. doi: 10.1161/hc4901.102568. PMID:11739319.
24. Liedtke, A.J., Nellis, S., and Neely, J.R. 1978. Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine. Circ. Res. 43: 652-661. doi:10.1161/01.RES.43.4.652. PMID:688564.
25. Narayanan, S. 1993. Aldose reductase and its inhibition in the control of diabetic complications. Ann. Clin. Lab. Sci. 23: 148-158. PMID:8457142.
26. Park, T.S., Hu, Y., Noh, H.L., Drosatos, K., Okajima, K., Buchanan, J., et al. 2008. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J. Lipid Res. 49: 2101- 2112. doi:10.1194/jlr.M800147-JLR200. PMID:18515784.
27. Poirier, P., Bogaty, P., Garneau, C., Marois, L., and Dumesnil, J.G. 2001. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care, 24: 5-10. doi:10.2337/diacare.24.1.5. PMID:11194240.
28. 2++ ATPase downregulation after myocardial infarction. Free Radic. Biol. Med. 40: 1827-1842. doi:10.1016/j.freeradbiomed.2006.01.019. PMID: 16678021.
29. Remme, W.J., Swedberg, K., and Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. 2001. Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 22: 1527- 1560. doi:10.1053/euhj.2001.2783. PMID:11492984.
30. Rubler, S., Dlugash, J., Yuceoglu, Y.Z., Kumral, T., Branwood, A.W., and Grishman, A. 1972. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol. 30: 595-602. doi:10.1016/0002-9149(72) 90595-4. PMID:4263660.
31. Schaffer, J.E. 2003. Lipotoxicity: when tissues overeat. Curr. Opin. Lipidol. 14: 281-287. doi:10.1097/00041433-200306000-00008. PMID:12840659.
32. Schannwell, C.M., Schneppenheim, M., Perings, S., Plehn, G., and Strauer, B.E. 2002. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology, 98: 33-39. doi:10.1159/000064682. PMID: 12373045.
33. Seddon, M., Shah, A.M., and Casadei, B. 2007. Cardiomyocytes as effectors of nitric oxide signalling. Cardiovasc. Res. 75: 315-326. doi:10.1016/j.cardiores. 2007.04.031. PMID:17568574.
34. Severson, D.L. 2004. Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Can. J. Physiol. Pharmacol. 82(10): 813-823. doi:10.1139/y04-065. PMID:15573141.
35. Sharma, V., and McNeill, J.H. 2006. Diabetic cardiomyopathy: where are we 40 years later? Can. J. Cardiol. 22: 305-308. doi:10.1016/S0828-282X(06)70914-X. PMID:16568154.
36. Sharma, V., Dhillon, P., Wambolt, R., Parsons, H., Brownsey, R., Allard, M.F., and McNeill, J.H. 2008a. Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat. Am. J. Physiol. Heart Circ. Physiol. 294: H1609-H1620. doi:10.1152/ajpheart.00949.2007. PMID: 18203848.
37. Sharma, V., Parsons, H., Allard, M.F., and McNeill, J.H. 2008b. Metoprolol increases the expression of beta(3)-adrenoceptors in the diabetic heart: effects on nitric oxide signaling and forkhead transcription factor-3. Eur. J. Pharmacol. 595: 44-51. doi:10.1016/j.ejphar.2008.07.042. PMID:18703049.
38. Sharma, V., Sharma, A., Saran, V., Bernatchez, P.N., Allard, M.F., and McNeill, J.H. 2011. Beta-receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions. Eur. J. Pharmacol. 657: 117-125. doi:10.1016/j.ejphar.2011.01.044. PMID: 21296063.
39. UBC Department of Statistics. 2012. Statistical Consulting and Research Laboratory.
40. Weigert, C., Brodbeck, K., Lehmann, R., Haring, H.U., and Schleicher, E.D. 2001. Overexpression of glutamine:fructose-6-phosphate-amidotransferase induces transforming growth factor-beta1 synthesis in NIH-3T3 fibroblasts. FEBS Lett. 488: 95-99. doi:10.1016/S0014-5793(00)02395-4. PMID:11163803.